The committee concluded that there is evidence that SecurAcath is effective for securing peripherally inserted central catheters (PICCs). Using SecurAcath avoids the need for securement device replacement and is associated with a low incidence of catheter-associated complications, such as migration, occlusion, thrombosis and infection.
The committee concluded that SecurAcath is easy to use and is well tolerated by people with PICCs, provided that device placement is done by staff with appropriate training and experience.
The committee concluded that the adoption of SecurAcath for the securement of PICCs is likely to be cost saving compared with StatLock, with cost savings resulting from a reduction in the time taken during weekly dressing changes and from avoiding securement device replacement. Cost savings are greater with longer PICC dwell times, with cost modelling indicating that using SecurAcath becomes cost saving when the catheter is expected to be in place for 15 days or more.